loader
Please Wait
Applying Filters...

List of Drug Master Files (DMF) for 13867 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Divis Laboratories

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Boulder Peptide 2024
Not Confirmed

Looking for Drug Master Files (DMF) for 13867 of Divis Laboratories Ltd

Looking for Drug Master Files (DMF) for 13867 of Divis Laboratories Ltd 1

20

Divis Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is NAPROXEN SODIUM USP, with a corresponding US DMF Number 13867.

Remarkably, this DMF maintains an Active status since its submission on November 27, 1998, highlighting commitment to regulatory compliance.

Their GDUFA DMF Review was successfully complete, with a review date of August 07, 2013, and payment made on July 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II